| Listed site | cdmo | cdmo |
|---|
| Summary | Contract process R&D and cGMP manufacturing for small molecule pharmaceuticals, specializing in high-potent compounds, controlled substances, crystallization development, and analytical services across Phase 1–3 clinical programs. | Integrated CRDMO offering discovery, development, and manufacturing services for small molecule NCE programs across 280+ global pharma and biotech clients. |
|---|
| Services | - Process Development
- CMC Analytical Development
- Stability Testing & Storage
- Formulation Development
- HPAPI Manufacturing (High-Potency)
- Controlled Substance Manufacturing
- Flow Chemistry & Continuous Manufacturing
- ADC Payload & Linker Synthesis
- Quality Control Testing
- Solid-State Chemistry & Polymorph Screening
| - CMC Analytical Development
- Process Development
- Stability Testing & Storage
- Technology Transfer
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- ADC Payload & Linker Synthesis
- Flow Chemistry & Continuous Manufacturing
- CMC Regulatory Submission Support
- Solid-State Chemistry & Polymorph Screening
- Formulation Development
- Quality Control Testing
|
|---|
| Modalities | - Small Molecule
- Antibody-Drug Conjugate (ADC)
| - Small Molecule
- Antibody-Drug Conjugate (ADC)
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | | - Headquarters, India, India
- UK Office, UK, United Kingdom
- USA Office, USA, United States
- Boston Laboratory, Boston, Massachusetts, USA
- Headquarters, Hyderabad, Telangana, India
- Bidar Campus (Unit IV & VI), Bidar, Karnataka, India
- Boston, Boston, Massachusetts, USA
- UK Facility, United Kingdom
- UK Operations, United Kingdom
- Bidar Campus (API Manufacturing), Bidar, Karnataka, India
- Integrated R&D Campus, Hyderabad, Telangana, India
- Boston Area Site, Boston, Massachusetts, USA
|
|---|
| Certifications | Data not yet provided. | - USFDA · Identifier: 21 CFR Part 210 and 211
- EU · Identifier: EU cGMP guidelines
- TGA · Identifier: TGA guidelines
- India · Identifier: Schedule M (Indian cGMP standards)
- My Green Lab (MGL) · Identifier: Green Lab Certification (98%+ compliance score)
- BSE · Identifier: 544306
- NSE · Identifier: SAILIFE
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|